PREVENTION AND TREATMENT OF KIDNEY INJURY IN PATIENTS WITH URATE DYSMETABOLISM
- Authors: Shcherbak A.1, Bobkova I.1, Kozlovskaya L.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 24, No 6 (2013)
- Pages: 6-10
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115640
- ID: 115640
Cite item
Open Access
Access granted
Abstract
The paper shows the clinical variants of kidney injury in urate dysmetabolism (UD). It unveils current examination principles, by assessing the clinical and laboratory criteria for the diagnosis of UD in different forms of kidney injuries. Guidelines for its treatment and non-drug correction and their indications are discussed. The promising areas of UD treatment and prevention, including the drugs that are passing clinical trials, are presented.
Full Text
About the authors
A. Shcherbak
I.M. Sechenov First Moscow State Medical University
Email: annard@yandex.ru
I. Bobkova
I.M. Sechenov First Moscow State Medical University
L. Kozlovskaya
I.M. Sechenov First Moscow State Medical University
References
- Козловская Л.В., Мухин Н.А., Бобкова И.Н и др. Значение исследования в моче молекулярных медиаторов воспаления и фиброза при хроническом гломерулонефрите // Тер. арх. - 2004; 9: 84-9.
- Мухин Н.А., Фомин В.В., Лебедева М.В. Гиперурикемия как компонент кардиоренального синдрома // Тер. арх. - 2011; 6: 5-12.
- Мухин Н.А., Моисеев С.В., Фомин В.В. и др. Урикозурическое действие лозартана // Клин. фарм. и тер. - 2003; 3: 50-3.
- Мухин Н.А., Балкаров И.М., Лебедева М.В. и др. Уратная нефропатия -от «бессимптомной» гиперурикозурии до хронического гемодиализа // Нефрология. - 1997; 3 (1): 7-10.
- Beck L. Requiem for gouty nephropathy // Kidney Int. - 1986; 30 (2): 280-7.
- Becker M. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout) // Rheum. Dis. Clin. North. Am. - 1988; 14: 377.
- Becker M., Kisicki J., Khosravan R. et al. Febuxostat (TMX-67), a novel, nonpurine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers // Nucleos. Nucleot. Nucleic. Acids. - 2004; 23: 1111.
- Bellomo G., Venanzi S., Verdura C. et al. Association of uric acid with change in kidney function in healthy normotensive individuals // Am. J. Kidney Dis. - 2010; 56: 264.
- Burns C., Robert L. Latest evidence on gout management: what the clinician needs to know // Ther. Adv. Chronic Dis. - 2012; 3 (6): 271-86.
- Chessman D., Kostenko L. et al. Human lucocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity // Immunity. - 2008, 28: 822-32.
- Coiffier B., Altman A., Pui C.H. et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review // J. Clin. Oncol. - 2008; 26: 2767.
- Doherty M. New insights into the epidemiology of gout // Rheumatology. -2009; 48 (2): 2-8.
- Johnson R., Kivlighn S., Kim Y. et al. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease // Am. J. Kidney Dis. - 1999; 33: 225.
- Kenny J., Goldfarb D. Update on the pathophysiology and management of uric acid renal stones // Curr. Rheumatol. Rep. - 2010; 12: 125.
- Matlaga B., Kawamoto S., Fishman E. Dual source computed tomography: a novel technique to determine stone composition // Urology. - 2008; 72: 1164.
- Riches P. et al. Recent insights into the pathogenesis of hyperuricaemia and gout // Hum. Mol. Genet. - 2009; 18: 177-84.
- Rose B. Pathophysiology of Renal Disease, 2d ed., McGraw-Hill // New York. -1987; p. 418-25.
- Ryu E., Kim M., Shin H. et al. Uric Acid-induced Phenotypic Transition of Renal Tubular Cells as a Novel Mechanism of Chronic Kidney Disease // Am. J. Physiol. Renal. Physiol. - 2013; 2: 137-9.
- Shekarriz B., Stoller M.L. Uric acid nephrolithiasis: current concepts and controversies // J. Urol. - 2002; 168: 1307.
- Trinchieri A., Esposito N., Castelnuovo C. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate // Arch. Ital. Urol. Androl. - 2009; 81: 188.
Supplementary files
